273 parallel-processing-bioinformatics "https:" Postdoctoral positions at Nature Careers
Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
bioinformatic analyses and/or animal work. Applicants must possess a Ph.D. or M.D. Ph.D. in molecular biology, biochemistry or a related field and should have no more than two years of post-doctoral experience
-
biological, biochemical as well as -omics and bioinformatics techniques Optimize and apply ribosome profiling and single-cell ribosome profiling on organoids and clinical samples Characterize the impact of gut
-
Experience with at least two of the following: flow cytometry, microscopy, NGS techniques and analysis, CRISPR-based epigenetic or genome editing Interest and ideally hands-on experience in bioinformatics
-
on the design and control of a robotic system for the maintenance of DEMO breeding blankets, in close collaboration with key EU fusion partners. https://mpe.au.dk/en/research/key-areas-in-research-and-development
-
2021; Khoshkhoo et al. JAMA Neurology 2023; Farrell et al. Nature 2024; Bizzotto et al. PNAS 2025; Khoshkhoo et al. bioRxiv 2026. For more information, please check our websites at https
-
to Dr. Divij Verma at Divij.verma@einsteinmed.edu Closing Applications will be accepted on a rolling basis until the position is filled. For more information about our work, visit https
-
designs. Visit his group webpage (http://mbg.au.dk/yuya-hayashi/ ) for further information. Yuya also organises a cross-departmental network of extracellular vesicle researchers at Aarhus University, EVAnet
-
veteran status. If you are unable to use our online application process due to an impairment or disability, please contact 814-865-1473. The Pennsylvania State University is committed to and accountable
-
position is full-time, starting 1 June 2026 (or as soon as possible thereafter), and is initially for two years. As part of the recruitment process, a shortlisting procedure will be applied. Expected start
-
our publications here . Our team is at the forefront of bringing autologous cell replacement therapies with CRISPR-edited muscle stem cells towards the clinic (https://www.mdc-berlin.de/news/news/deep